Core Laboratories NV Company Profile (NYSE:CLB)

About Core Laboratories NV

Core Laboratories NV logoCore Laboratories N.V. is a provider of reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company's services and products are directed toward enabling the Company's clients to improve reservoir performance and increase oil and gas recovery from their producing fields. The Company has over 70 offices in over 50 countries. The Company operates in three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and improve recovery of oil and gas from the Company's clients' reservoirs.

Industry, Sector and Symbol:
  • Sector: Oils/Energy
  • Industry: Oil & Gas Equipment & Services
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: CLB
  • CUSIP:
Key Metrics:
  • Previous Close: $105.21
  • 50 Day Moving Average: $109.84
  • 200 Day Moving Average: $117.61
  • 52-Week Range: $84.50 - $135.49
  • Trailing P/E Ratio: 71.28
  • Foreward P/E Ratio: 49.16
  • P/E Growth: 6.29
  • Market Cap: $4.64B
  • Outstanding Shares: 44,319,000
  • Beta: 1.45
  • Net Margins: 10.17%
  • Return on Equity: 196.22%
  • Return on Assets: 12.68%
  • Debt-to-Equity Ratio: 1.25%
  • Current Ratio: 2.03%
  • Quick Ratio: 1.61%
Additional Links:
Companies Related to Core Laboratories NV:

Analyst Ratings

Consensus Ratings for Core Laboratories NV (NYSE:CLB) (?)
Ratings Breakdown: 3 Sell Ratings, 10 Hold Ratings, 8 Buy Ratings
Consensus Rating:Hold (Score: 2.24)
Consensus Price Target: $121.71 (15.68% upside)

Analysts' Ratings History for Core Laboratories NV (NYSE:CLB)
DateFirmActionRatingPrice TargetDetails
10/22/2016Cowen and CompanyReiterated RatingMarket Perform$105.00View Rating Details
10/11/2016Citigroup Inc.Boost Price TargetNeutral$110.00 -> $115.00View Rating Details
10/5/2016DA DavidsonInitiated CoverageBuy$136.00View Rating Details
9/30/2016Loop CapitalInitiated CoverageHold$120.00View Rating Details
9/1/2016Credit Suisse Group AGInitiated CoverageNeutral$115.00View Rating Details
7/12/2016JPMorgan Chase & Co.DowngradeNeutral -> UnderweightView Rating Details
6/13/2016KLR GroupReiterated RatingBuy$166.00 -> $180.00View Rating Details
4/23/2016Royal Bank Of CanadaReiterated RatingBuyView Rating Details
4/23/2016SimmonsReiterated RatingHold$105.00 -> $115.00View Rating Details
4/22/2016ABN AmroDowngradeBuy -> SellView Rating Details
4/22/2016StephensBoost Price TargetEqual Weight$89.00 -> $98.00View Rating Details
4/19/2016Morgan StanleyBoost Price TargetOverweight$120.00 -> $140.00View Rating Details
3/28/2016Howard WeilBoost Price Target$112.00View Rating Details
2/10/2016ING GroupLower Price TargetHold$125.00 -> $112.00View Rating Details
2/2/2016William BlairReiterated RatingOutperformView Rating Details
1/30/2016ScotiabankReiterated RatingSector Perform$117.00 -> $105.00View Rating Details
1/29/2016SunTrust Banks Inc.Lower Price TargetBuy$123.00 -> $109.00View Rating Details
1/29/2016Iberia CapitalLower Price TargetOutperform$140.00 -> $115.00View Rating Details
1/26/2016HSBCDowngradeHold -> ReduceView Rating Details
1/11/2016Oppenheimer Holdings Inc.Initiated CoverageMarket PerformView Rating Details
11/30/2015GuggenheimUpgradeNeutral -> Buy$135.00View Rating Details
9/30/2015Sterne Agee CRTLower Price TargetNeutral$113.00 -> $108.00View Rating Details
(Data available from 10/25/2014 forward)


Earnings History for Core Laboratories NV (NYSE:CLB)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/19/2016Q316$0.38$0.38$155.72 million$143.50 millionViewN/AView Earnings Details
7/20/2016Q216$0.35$0.35$146.37 million$148.10 millionViewN/AView Earnings Details
4/20/2016Q116$0.37$0.37$161.24 million$153.65 millionViewN/AView Earnings Details
1/27/2016Q415$0.65$0.65$179.48 million$182.70 millionViewListenView Earnings Details
10/21/2015Q315$0.83$0.83$203.29 million$197.27 millionViewListenView Earnings Details
7/22/2015Q215$0.77$0.82$195.13 million$204.00 millionViewListenView Earnings Details
4/22/2015Q115$0.85$0.86$211.82 million$213.64 millionViewN/AView Earnings Details
1/28/2015Q414$1.54$1.54$280.18 million$278.60 millionViewN/AView Earnings Details
10/22/2014Q314$1.51$1.53$284.30 million$276.14 millionViewListenView Earnings Details
7/23/2014Q214$1.34$1.35$269.70 million$267.56 millionViewListenView Earnings Details
4/23/2014Q114$1.45$1.35$283.02 million$262.90 millionViewListenView Earnings Details
1/30/2014Q413$1.40$1.43$278.55 million$276.30 millionViewListenView Earnings Details
10/17/2013Q313$1.34$1.36$267.21 million$273.16 millionViewN/AView Earnings Details
7/17/2013Q2 2013$1.31$1.32$267.24 million$263.14 millionViewListenView Earnings Details
4/17/2013Q1 2013$1.15$1.22$260.90 million$260.90 millionViewListenView Earnings Details
1/30/2013Q4 2012$1.13$1.17$246.49 million$254.46 millionViewListenView Earnings Details
10/17/2012$1.10$1.13ViewN/AView Earnings Details
7/18/2012$1.16$1.16ViewN/AView Earnings Details
4/18/2012$1.07$1.06ViewN/AView Earnings Details
2/1/2012$1.08$1.09ViewN/AView Earnings Details
10/19/2011$0.99$0.93ViewN/AView Earnings Details
4/19/2011$0.75$0.77ViewN/AView Earnings Details
2/9/2011$0.81$0.84ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Core Laboratories NV (NYSE:CLB)
Current Year EPS Consensus Estimate: $1.53 EPS
Next Year EPS Consensus Estimate: $2.14 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20166$0.35$0.75$0.53
Q2 20163$0.27$0.72$0.45
Q3 20164$0.28$0.77$0.46
Q4 20164$0.32$0.76$0.48
Q1 20173$0.41$0.81$0.57
Q2 20173$0.44$0.88$0.62
Q3 20173$0.48$0.97$0.70
Q4 20173$0.45$1.03$0.75
(Data provided by Zacks Investment Research)


Current Dividend Information for Core Laboratories NV (NYSE:CLB)
Annual Dividend:$2.20
Dividend Yield:2.09%
Dividend Growth:25.20% (3 Year Average)
Payout Ratio:149.66% (Based on Trailing 12 Months of Earnings)
143.79% (Based on Current Year Consensus EPS Estimate)
102.80% (Based on Next Year Consensus EPS Estimate)
Track Record:6 Years of Consecutive Dividend Growth

Dividend History for Core Laboratories NV (NYSE:CLB)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Core Laboratories NV (NYSE:CLB)
Insider Ownership Percentage: 1.00%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/2/2016Jan Willem SodderlandDirectorBuy300$93.90$28,170.00View SEC Filing  
5/12/2015Michael C KearneyDirectorSell1,000$128.52$128,520.00View SEC Filing  
11/17/2014Mark F ElvigVPSell1,000$138.03$138,030.00View SEC Filing  
7/28/2014Richard L BergmarkCFOBuy7,000$147.31$1,031,170.00View SEC Filing  
3/7/2014Michael KearneyDirectorSell2,000$193.00$386,000.00View SEC Filing  
2/14/2014Mark ElvigVPSell1,500$186.64$279,960.00View SEC Filing  
10/21/2013Monty L DavisCOOSell5,704$197.33$1,125,570.32View SEC Filing  
8/7/2013Richard BergmarkCFOSell20,000$149.58$2,991,600.00View SEC Filing  
7/25/2013Charles Brigham MillerCAOSell11,648$147.81$1,721,690.88View SEC Filing  
7/25/2013Monty L DavisCOOSell5,948$149.12$886,965.76View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Core Laboratories NV (NYSE:CLB)
DateHeadline logoCorrection: Earns-Core Laboratories story (NYSE:CLB) - October 22 at 4:07 PM logoCore Laboratories NV (CLB) CEO David Demshur on Q3 2016 Results - Earnings Call Transcript (NYSE:CLB) - October 22 at 4:07 PM logoCore Laboratories (CLB) Meets Q3 Earnings, Lags Revenues (revised) (NYSE:CLB) - October 21 at 4:15 PM logoCORE LABORATORIES N V Files SEC form 10-Q, Quarterly Report (NYSE:CLB) - October 21 at 4:15 PM
News IconPumping the Brakes, Stock Gapping Downward: Core Laboratories NV (NYSE:CLB) - CSZ News (NYSE:CLB) - October 21 at 12:34 PM logoEarnings Reaction History: Core Laboratories N V, 60.0% Follow-Through Indicator, 6.2% Sensitive - Nasdaq (NYSE:CLB) - October 20 at 3:45 PM logoCore Laboratories NV (CLB) CEO David Demshur on Q3 2016 Results - Earnings Call Transcript - Seeking Alpha (NYSE:CLB) - October 20 at 3:45 PM logoCore Laboratories misses Street 3Q forecasts (NYSE:CLB) - October 20 at 9:04 AM logoCore Lab Reports Third-Quarter 2016 Results (NYSE:CLB) - October 20 at 9:04 AM logoCore Laboratories N.V. Earnings Flatten Out (NYSE:CLB) - October 20 at 9:04 AM logoQ3 2016 Core Laboratories NV Earnings Release - After Market Close (NYSE:CLB) - October 19 at 9:12 AM logoOil Stocks Q3 Earnings Slated on Oct 19: CLB, FTI, HAL, KMI - Nasdaq (NYSE:CLB) - October 18 at 4:11 PM logoWhat Are Patterson-UTI Energy’s Strategies for 3Q16? (NYSE:CLB) - October 18 at 4:11 PM
News IconCore Laboratories NV (NYSE:CLB) earnings expectations | The ... - The Independent Republic (NYSE:CLB) - October 18 at 9:16 AM logoDavid Rolfe Comments on Core Labs (NYSE:CLB) - October 18 at 9:16 AM logoWedgewood Partners 3rd Quarter Letter: Is Indexation Investing the New Momentum Speculation? (NYSE:CLB) - October 17 at 4:10 PM
News IconCore Laboratories NV (CLB) Price Target Raised to $115.00 - DailyQuint (NYSE:CLB) - October 17 at 9:10 AM logoIs Shorting Core Laboratories Still a Popular Trade? (NYSE:CLB) - October 17 at 9:10 AM logoCore Laboratories NV breached its 50 day moving average in a Bearish Manner : CLB-US : October 17, 2016 (NYSE:CLB) - October 17 at 9:10 AM
News IconUpdate on Core Laboratories NV (NYSE:CLB) for the day (NYSE:CLB) - October 15 at 4:08 PM
News IconBargain-Counter Stock or Pricey? Update on Core Laboratories NV (NYSE:CLB) - CSZ News (NYSE:CLB) - October 15 at 9:03 AM
News IconCore Laboratories NV (CLB) – Analysts' Recent Ratings Updates - Evergreen Investor (NYSE:CLB) - October 15 at 9:03 AM logoWhat CLB’s Management Finds to Be Most Crucial to Address (NYSE:CLB) - October 14 at 4:07 PM logoCore Laboratories Strategizes to Improve Its Segment Revenues (NYSE:CLB) - October 14 at 10:31 AM
News IconStock Trend Anchored Above Moving Averages: Core Laboratories NV (NYSE:CLB) - Recall News (NYSE:CLB) - October 12 at 8:53 AM logoCore Laboratories declares $0.55 dividend (NYSE:CLB) - October 11 at 4:46 PM logoCore Laboratories NV – Value Analysis (NYSE:CLB) : October 10, 2016 (NYSE:CLB) - October 10 at 4:05 PM logo3 Little-Known Oil and Gas Companies to Put on Your Radar (NYSE:CLB) - October 9 at 8:48 AM logo3 Top Oil Stocks to Buy in October (NYSE:CLB) - October 8 at 9:49 AM logoCore Labs' Innovation And Cutting Edge Tech Make It A Core Holding (NYSE:CLB) - October 7 at 9:08 AM logoCore Laboratories NV breached its 50 day moving average in a Bullish Manner : CLB-US : October 7, 2016 (NYSE:CLB) - October 7 at 9:08 AM logoCore Labs Shares Receive New Buy Recommendation At D.A. Davidson (NYSE:CLB) - October 6 at 4:10 PM logoCore Laboratories NV : CLB-US: Dividend Analysis : July 18th, 2016 (record date) : By the numbers : October 5, 2016 (NYSE:CLB) - October 5 at 4:29 PM logoTop 5 well managed oilfield services companies by ROIC (return on invested capital). : October 5, 2016 (NYSE:CLB) - October 5 at 4:29 PM
News IconCore Laboratories NV (NYSE:CLB) Price Target & Session Check - Recall News (NYSE:CLB) - October 5 at 9:26 AM logoCore Laboratories' Third Quarter 2016 Webcast At 7:30 A.M. CDT / 2:30 P.M. CEST On October 20, 2016 (NYSE:CLB) - October 4 at 4:12 PM logoCore Laboratories N.V. (NYSE:CLB) Bearish Target At $98 - Investor Newswire (NYSE:CLB) - October 2 at 3:59 PM logoHere are 3 Oil Stocks That Stand to Benefit the Most From OPEC's ... - Motley Fool (NYSE:CLB) - October 1 at 9:45 AM
News IconLoop Capital Initiates Coverage on Core Laboratories NV (CLB) (NYSE:CLB) - September 30 at 4:41 PM
News IconThe Key Numbers To Watch From Core Laboratories NV (NYSE ... - The Voice Registrar (NYSE:CLB) - September 26 at 4:29 PM logoCore Laboratories N.V. (NYSE:CLB) Had $22.494 In Cash And Short-Term Investments (NYSE:CLB) - September 24 at 4:05 PM logoCore Laboratories NV (NYSE:CLB) Had $22.494 In Cash And Short-Term Investments - Stocks Daily (NYSE:CLB) - September 24 at 8:29 AM
News IconCore Laboratories PT Lowered to $116.00 (CLB) - Petro Global News 24 (NYSE:CLB) - September 21 at 4:53 PM logoCore Lab Presents At Johnson Rice Energy Conference - PR Newswire (press release) (NYSE:CLB) - September 21 at 4:53 PM logoCORE LABORATORIES N V Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NYSE:CLB) - September 21 at 8:17 AM logoCore Lab Presents At Johnson Rice Energy Conference (NYSE:CLB) - September 21 at 8:17 AM logoHow SPN’s Current Valuation Compares to Its Peers’ (NYSE:CLB) - September 21 at 8:17 AM logoBullish Target For Core Laboratories N.V. (NYSE:CLB) At $150 - Investor Newswire (NYSE:CLB) - September 19 at 5:01 PM
News IconAnalysts Take Aim At This Stock's Earnings Estimates: Core Laboratories N.V. (NYSE:CLB) - Frisco Fastball (NYSE:CLB) - September 19 at 5:01 PM logoCore Laboratories N.V. (NYSE:CLB) Held $22.494 In Cash And Short-Term Investments (NYSE:CLB) - September 16 at 4:07 PM


Core Laboratories NV (NYSE:CLB) Chart for Tuesday, October, 25, 2016

Last Updated on 10/25/2016 by Staff